VALLEY NATIONAL ADVISERS INC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 773411
BETHLEHEM, PA
Position in VRTX
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$94,875
+$8,247 QoQ
Shares Held
191
-1.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,453
of 1,705 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VALLEY NATIONAL ADVISERS INC holds $1,028,190 across 22 Biotechnology names. VRTX ranks #2 (9.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,091 | $680,282 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
191 | $94,875 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
161 | $86,448 | |
| 4 | CRSP |
CRISPR Therapeutics AG
|
1,000 | $54,540 | |
| 5 | VTVT |
vTv Therapeutics Inc.
|
980 | $36,897 | |
| 6 | MRNA |
Moderna, Inc.
|
329 | $23,039 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
200 | $16,302 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
350 | $13,653 |
All Filings in VRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $94,875 | 191 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $86,628 | 194 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $83,871 | 185 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $72,453 | 185 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $73,012 | 164 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $79,995 | 165 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $49,129 | 122 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $56,739 | 122 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $75,463 | 161 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $63,119 | 151 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $70,798 | 174 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $45,553 | 131 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $44,340 | 126 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $39,698 | 126 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $36,386 | 126 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $36,482 | 126 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $34,378 | 122 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $31,838 | 122 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $26,791 | 122 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $20,315 | 112 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $25,405 | 126 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $27,076 | 126 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $29,778 | 126 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $34,287 | 126 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $36,579 | 126 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $26,650 | 112 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||